CASP3 and sarcoma: Like ISRE activity and STAT1 protein, levels of cleaved caspase-3 were increased in human sarcoma (2fTGH) cells expressing the F425I TOS mutant (Fig. 6A - lane 5), and the enhancing effect of rapamycin on apoptosis was lost (Fig. 6A – lane 6).